Shakir Douraid K, Zubaid Mohammad, Al-Mallah Mouaz H, Al-Mahmeed Wael, Alsheikh-Ali Alawi A, Singh Rajvir, Amin Haitham, Rao Nayan, Suwaidi Jassim Al
Department of Cardiology and Cardiovascular Surgery, Hamad Medical Corporation (HMC), Doha, Qatar.
Acta Cardiol. 2011 Apr;66(2):203-11. doi: 10.1080/ac.66.2.2071252.
Little is known about the prevalence and prognostic implications of major bleeding complications among patients admitted with acute coronary syndrome (ACS) in the Middle East. We describe the prevalence and outcome of ACS in Middle Eastern patients with and without major bleeding complications.
The Gulf Registry of Acute Coronary Events (Gulf RACE) is a prospective, multinational registry conducted for 6 months in 2007 for patients hospitalized with the final diagnosis of ACS in 65 centres in six adjacent Middle Eastern countries. There were no exclusion criteria. A total of 8166 patients were stratified according to the development of major bleeding complications during the index admission.
Compared to patients without bleeding complications, patients with major bleeding (68 patients, 0.83%) were significantly older, and had ST-segment elevation myocardial infarction. However, there were no significant differences between the two groups with regard to sex, other cardiovascular risk factors, or use of antiplatelet and antithrombotic therapy. Patients with bleeding complications had worse in-hospital outcomes including death, congestive heart failure, cardiogenic shock, recurrent myocardial infarction, and stroke. After adjusting for baseline characteristics, major bleeding was independently associated with a more than 5-fold increase in in-hospital mortality (odds ratio 5.2, 95% confidence interval 2.8-10.1, P < 0.001).
Similar to Western studies, bleeding in the setting of ACS is a powerful and independent predictor of poor in-hospital outcomes in patients admitted with ACS in the Middle East.
关于中东地区急性冠脉综合征(ACS)患者中严重出血并发症的患病率及其对预后的影响,人们了解甚少。我们描述了有和没有严重出血并发症的中东ACS患者的患病率及预后情况。
海湾急性冠脉事件注册研究(Gulf RACE)是一项前瞻性、跨国注册研究,于2007年在中东六个相邻国家的65个中心,针对最终诊断为ACS的住院患者进行了为期6个月的研究。没有排除标准。根据首次住院期间严重出血并发症的发生情况,将8166例患者进行分层。
与无出血并发症的患者相比,发生严重出血的患者(68例,0.83%)年龄显著更大,且患有ST段抬高型心肌梗死。然而,两组在性别、其他心血管危险因素或抗血小板及抗血栓治疗的使用方面没有显著差异。有出血并发症的患者住院结局更差,包括死亡、充血性心力衰竭、心源性休克、再发性心肌梗死和中风。在对基线特征进行调整后,严重出血与住院死亡率增加超过5倍独立相关(比值比5.2,95%置信区间2.8 - 10.1,P < 0.001)。
与西方研究相似,在中东地区,ACS患者发生出血是住院结局不良的一个有力且独立的预测因素。